Availability of Sanofi Pasteur 2019-2020 Influenza Vaccines

Oct 24, 2019

Availability of Sanofi Pasteur 2019-2020 Influenza Vaccines

Sanofi Pasteur does not have a shortage of any presentation of influenza vaccine for the 2019/2020 season.

Sanofi Pasteur is on track to deliver approximately 70 million doses of influenza vaccine to all of our US customers in line with the delivery schedule that was communicated to our customers in June once we assessed the impact of the delayed strain selection on our production timeline.

To date, we have delivered 75% of all doses ordered by our US customers for the 2019-2020 influenza season.  Delivery of orders will continue into November to support ongoing immunization campaigns.  We communicated these shipment dates to all of our customers who reserved influenza vaccines with us, including Fluzone® High-Dose vaccine.  Sanofi Pasteur does not have a shortage of any presentation of influenza vaccine.

AVAILBILITY OF HIGH-DOSE VACCINES

To date, we have delivered nearly 70% of all orders for Fluzone® High-Dose and have communicated future delivery dates for the remaining orders. The only other “higher dose” vaccine available for use this season is Flublok® Quadrivalent Influenza Vaccine, which is currently available for immediate delivery. Any customer needing additional “higher dose” products can call 1-800-VACCINE or log onto www.vaccineshoppe.com to place a Flublok order for immediate delivery.

If there are questions related to the availability of non-Sanofi Pasteur products, please contact the manufacturers.